Roles of Macropinocytosis in HIV-1 infection of CD4+ T Cells
Roles of Macropinocytosis in HIV-1 infection of CD4+ T Cells
批准号:
10412160
负责人:
PHILIP D KING
金额:
$65.25万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-06-23 至 2026-05-31
关键词:
Acquired Immunodeficiency SyndromeAffectBindingBiologyCCR5 geneCD4 Positive T LymphocytesCXCR4 geneCapsidCell LineCell NucleusCell fusionCell membraneCell physiologyCell surfaceCellsClathrinComplexConflict (Psychology)CytoplasmDataEndocytosisEnvironmentEventGenesGeneticGoalsHIVHIV Envelope Protein gp120HIV InfectionsHIV-1HumanImmunologyInfectionKnowledgeLaboratoriesLocationMediatingMetabolismMicroscopicMolecularMolecular ConformationN-terminalNatureOutcomePathway interactionsPeptidesPharmacologyPlayPrimary InfectionProcessPropertyReportingResearchRoleSignal TransductionSurfaceT-LymphocyteTestingViralVirionVirusVirus Diseasescell typeenv Glycoproteinsexperimental studyimprovednovelparticlereceptorreceptor bindingsmall molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Title: Roles of Macropinocytosis in HIV-1 infection of CD4+ T Cells
Project Summary:
Host cell entry is the first step in the replication cycle of HIV-1, the causative agent of AIDS. Although receptor
binding of viral Env glycoprotein and subsequent virus-cell fusion during the virus entry process have been
described in detail, subcellular locations of these events remain to be determined. In particular, despite the
importance of CD4+ T lymphocytes as a natural host cell type for HIV-1, the contribution of virion endocytosis
to HIV-1 infection of CD4+ T cells remains poorly understood. Previous studies of HIV-1 entry into T cells have
largely focused on clathrin-mediated endocytosis and cell surface fusion. However, our team recently
discovered that primary CD4+ T cells engage in robust macropinocytosis, a large-scale, clathrin-independent
form of endocytosis. Importantly, our preliminary data indicate that pharmacological inhibition of
macropinocytosis blocks both internalization of HIV-1 particles and productive infection in primary human
CD4+ T cells. In contrast, the same treatment does not affect HIV infection of a commonly used CD4+ T cell
line. These results suggest that the macropinocytic entry is a hitherto overlooked mode of HIV-1 entry that
contributes to infection of primary human CD4+ T cells. Interestingly, our preliminary study also showed that
inhibition of macropinocytosis after completion of virus internalization also blocks expression of virus-encoded
genes, suggesting that macropinocytosis has another later role in productive HIV infection, which is separable
from virus internalization. In the current application, we propose to determine the roles of macropinocytosis in
productive infection of primary CD4+ T cells. Our long-term goal is to fully describe cellular mechanisms that
promote HIV-1 infection and to use the obtained knowledge for developing antiviral strategies. Our central
hypothesis in this application is that macropinocytosis in primary human CD4+ T cells contributes to productive
infection as a major HIV-1 entry pathway and as a cellular function necessary for maintaining a permissive
environment for the virus. To test this hypothesis, we plan to determine: 1) the extent to which macropinocytic
internalization contributes to productive HIV entry into primary human CD4+ T cells; 2) the roles played by
Env-receptor interactions in promoting HIV-1 macropinocytosis; 3) the influence of macropinosome
environment on HIV-1 entry; and 4) the nature of post-internalization macropinocytosis function that promotes
productive infection. The outcomes of the experiments outlined in this proposal will likely fill the knowledge gap
in our understanding of HIV-1 entry, a fundamental aspect of the HIV-1 replication cycle, and help us develop
or improve antiviral strategies that target virus entry and establishment of productive infection in CD4+ T cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Roles of Macropinocytosis in HIV-1 infection of CD4+ T Cells
-
批准号:10652492
-
项目类别:
-
资助金额:$64.25万
-
财政年份:2022
-
负责人:PHILIP D KING
-
依托单位:
The Structure and Function of Dental Lymphatics (R21)
-
批准号:10388309
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2021
-
负责人:PHILIP D KING
-
依托单位:
Molecular pathogenetic mechanisms in CM-AVM
-
批准号:9883235
-
项目类别:
-
资助金额:$60.32万
-
财政年份:2020
-
负责人:PHILIP D KING
-
依托单位:
Molecular pathogenetic mechanisms in CM-AVM
-
批准号:10534770
-
项目类别:
-
资助金额:$51.88万
-
财政年份:2020
-
负责人:PHILIP D KING
-
依托单位:
Molecular pathogenetic mechanisms in CM-AVM
-
批准号:10319562
-
项目类别:
-
资助金额:$51.88万
-
财政年份:2020
-
负责人:PHILIP D KING
-
依托单位:
Lymphatic Vessel Abnormalities in CM-AVM
-
批准号:8884207
-
项目类别:
-
资助金额:$39.72万
-
财政年份:2015
-
负责人:PHILIP D KING
-
依托单位:
EPHB4-RASA1 regulation of lymphatic vessel valve development and function
-
批准号:10543485
-
项目类别:
-
资助金额:$57.12万
-
财政年份:2015
-
负责人:PHILIP D KING
-
依托单位:
Lymphatic Vessel Abnormalities in CM-AVM
-
批准号:9034658
-
项目类别:
-
资助金额:$39.06万
-
财政年份:2015
-
负责人:PHILIP D KING
-
依托单位:
RASA1-mediated control of lymphatic vessel growth and function
-
批准号:8308412
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2009
-
负责人:PHILIP D KING
-
依托单位:
RASA1-mediated control of lymphatic vessel growth and function
-
批准号:7688995
-
项目类别:
-
资助金额:$37.29万
-
财政年份:2009
-
负责人:PHILIP D KING
-
依托单位:
RASA1-mediated control of lymphatic vessel growth and function
-
批准号:8126210
-
项目类别:
-
资助金额:$35.77万
-
财政年份:2009
-
负责人:PHILIP D KING
-
依托单位:
RASA1-mediated control of lymphatic vessel growth and function
-
批准号:7903263
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2009
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:7083748
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:6751203
-
项目类别:
-
资助金额:$28.19万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:6544850
-
项目类别:
-
资助金额:$13.95万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:6908115
-
项目类别:
-
资助金额:$29.08万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:6697024
-
项目类别:
-
资助金额:$16.18万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:6640313
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
REGULATION OF CD28 SIGNAL TRNSDUCTION
-
批准号:6511069
-
项目类别:
-
资助金额:$17.85万
-
财政年份:1999
-
负责人:PHILIP D KING
-
依托单位:
REGULATION OF CD28 SIGNAL TRNSDUCTION
-
批准号:6362394
-
项目类别:
-
资助金额:$20.9万
-
财政年份:1999
-
负责人:PHILIP D KING
-
依托单位:
海外基金